Authors:
VANDENBARK AA
CHOU YK
WHITHAM R
BOURDETTE DN
OFFNER H
Citation: Aa. Vandenbark et al., EFFECTS OF VACCINATION WITH T-CELL RECEPTOR-PEPTIDES - EPITOPE SWITCHING TO A POSSIBLE DISEASE-PROTECTIVE DETERMINANT OF MYELIN BASIC-PROTEIN THAT IS CROSS-REACTIVE WITH A TCR BV PEPTIDE, Immunology and cell biology, 76(1), 1998, pp. 83-90
Authors:
SIMON JH
JACOBS LD
CAMPION M
WENDE K
SIMONIAN N
COOKFAIR DL
RUDICK RA
HERNDON RM
RICHERT JR
SALAZAR AM
ALAM JJ
FISCHER JS
GOODKIN DE
GRANGER CV
LAJAUNIE M
MARTENSDAVIDSON AL
MEYER MJ
SHEEDER J
CHOI K
SCHERZINGER AL
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEINSTOCKGUTTMAN B
WHITHAM RH
Citation: Jh. Simon et al., MAGNETIC-RESONANCE STUDIES OF INTRAMUSCULAR INTERFERON BETA-1A FOR RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 79-87
Authors:
MURRAY S
SUBRAMANIAN S
BOURDETTE DN
JONES RE
Citation: S. Murray et al., SIMPLIFIED METHOD OF IDENTIFYING SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE VERSUS NON-SCID MICE BY FLOW CYTOMETRIC ANALYSIS OF PERIPHERAL-BLOOD, Cytometry, 32(4), 1998, pp. 274-279
Authors:
BOURDETTE DN
CHOU YK
WHITHAM RH
BUCKNER J
KWON HJ
NEPOM GT
BUENAFE A
COOPER SA
ALLEGRETTA M
HASHIM GA
OFFNER H
VANDENBARK AA
Citation: Dn. Bourdette et al., IMMUNITY TO T-CELL RECEPTOR PEPTIDES IN MULTIPLE-SCLEROSIS - III - PREFERENTIAL IMMUNOGENICITY OF COMPLEMENTARITY-DETERMINING REGION-2 PEPTIDES FROM DISEASE-ASSOCIATED T-CELL RECEPTOR BV GENES, The Journal of immunology (1950), 161(2), 1998, pp. 1034-1044
Authors:
VANDENBARK AA
CHOU YK
WHITMAN R
MASS R
BUENAFE A
LIEFELD D
KAVANAGH D
COOPER S
HASHIM GA
OFFNER H
BOURDETTE DN
Citation: Aa. Vandenbark et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH T-CELL RECEPTOR PEPTIDES - RESULTS OF A DOUBLE-BLIND PILOT TRIAL (VOL 2, PG 1109, 1996), Nature medicine, 3(2), 1997, pp. 240-240
Authors:
RUDICK RA
GOODKIN DE
JACOBS LD
COOKFAIR DL
HERNDON RM
RICHERT JR
SALAZAR AM
FISCHER JS
GRANGER CV
SIMON JH
ALAM JJ
SIMONIAN NA
CAMPION MK
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEISTOCKGUTTMAN B
WHITHAM RH
Citation: Ra. Rudick et al., IMPACT OF INTERFERON BETA-1A ON NEUROLOGIC DISABILITY IN RELAPSING MULTIPLE-SCLEROSIS, Neurology, 49(2), 1997, pp. 358-363
Authors:
WYNN ML
JOHNSTON WSW
MCCAULEY LA
SPENCER PS
REDMOND N
BOURDETTE DN
Citation: Ml. Wynn et al., ASSESSMENT OF VETERANS WITH PERSIAN-GULF-WAR UNEXPLAINED ILLNESSES - INITIAL RESULTS OF A POPULATION-BASED STUDY, Neurology, 48(3), 1997, pp. 2044-2044
Authors:
WEINBERG AD
BOURDETTE DN
SULLIVAN TJ
LEMON M
WALLIN JJ
MAZIARZ R
DAVEY M
PALIDA F
GODFREY W
ENGLEMAN E
FULTON RJ
OFFNER H
VANDENBARK AA
Citation: Ad. Weinberg et al., SELECTIVE DEPLETION OF MYELIN-REACTIVE T-CELLS WITH THE ANTI-OX-40 ANTIBODY AMELIORATES AUTOIMMUNE ENCEPHALOMYELITIS, Nature medicine, 2(2), 1996, pp. 183-189
Authors:
VANDENBARK AA
CHOU YK
WHITHAM R
MASS M
BUENAFE A
LIEFELD D
KAVANAGH D
COOPER S
HASHIM GA
OFFNER H
BOURDETTE DN
Citation: Aa. Vandenbark et al., TREATMENT OF MULTIPLE-SCLEROSIS WITH T-CELL RECEPTOR PEPTIDES - RESULTS OF A DOUBLE-BLIND PILOT TRIAL, Nature medicine, 2(10), 1996, pp. 1109-1115
Authors:
JACOBS LD
COOKFAIR DL
RUDICK RA
HERNDON RM
RICHERT JR
SALAZAR AM
FISCHER JS
GOODKIN DE
GRANGER CV
SIMON JH
ALAM JJ
BARTOSZAK DM
BOURDETTE DN
BRAIMAN J
BROWNSCHEIDLE CM
COATS ME
COHAN SL
DOUGHERTY DS
KINKEL RP
MASS MK
MUNSCHAUER FE
PRIORE RL
PULLICINO PM
SCHEROKMAN BJ
WEINSTOCKGUTTMAN B
WHITMAN RH
BAIRD WC
FILLMORE M
BONA LM
COLONRUIZ ME
NADINE BS
DONOVAN A
BENNETT S
KIEFFER YM
UMHAUER MA
MILLER CE
KILIC AK
SARGENT EL
SCHACHTER M
SHUCARD DW
WEIDER V
CATALANO BA
CERVI JM
CZEKAY C
FARRELL JL
FILIPPINI JS
MATYAS RC
MICHIENZI KE
ITO M
OMALLEY JA
ZIELEZNY MA
BRUN JM
DAVIDSON AL
GREEN LA
OREILLY KM
SHELTON JA
WENDE KE
BARILLA DY
BOYLE SL
PERKINS KK
PERRYMAN JE
STIEBELING BG
KONECSNI JF
ROSS JS
CHOI KS
GUSTAFSON CJ
QUANDT BJ
SCHERZINGER AL
GRIFFITH DA
HARRIS JM
LEZAK MD
MIMICA I
SAUNDERS JA
COIT WE
FORCE CR
GILMORE FJ
HARRIS LB
JONES MM
KAUFFMAN JA
MARBERGER KE
MCBRIDE JW
MILLER LL
WRIGHT GK
BROOKS JA
BROWN HR
GRAVES ME
SCHMIDT JA
MOTHENA JW
GRAFMAN JH
KENWORTHY MK
MORTON MM
BROWN DM
BROWN DC
LEVY LM
BORDEN EC
RANSOHOFF RM
VILCEK JT
MCCARTHYKIRBY K
CAMPION M
Citation: Ld. Jacobs et al., INTRAMUSCULAR INTERFERON BETA-1-ALPHA FOR DISEASE PROGRESSION IN RELAPSING MULTIPLE-SCLEROSIS, Annals of neurology, 39(3), 1996, pp. 285-294
Authors:
JONES RE
WESLEY S
THOMPSON M
JACOBS R
BOURDETTE DN
Citation: Re. Jones et al., PHENOTYPE AND FUNCTION OF HEMATOPOIETIC-DERIVED CELLS IN THE CNS OF SCID MOUSE-LEWIS RAT BONE-MARROW CHIMERAS, Journal of neuroscience research, 45(6), 1996, pp. 723-734
Authors:
CHOU YK
WEINBERG AD
BUENAFE A
BOURDETTE DN
WHITHAM R
KALEEBA JAR
ROBEY IF
KAVANAGH DG
OFFNER H
VANDENBARK AA
Citation: Yk. Chou et al., MHC-RESTRICTION, CYTOKINE PROFILE, AND IMMUNOREGULATORY EFFECTS OF HUMAN T-CELLS SPECIFIC FOR TCR V-BETA CDR2 PEPTIDES - COMPARISON WITH MYELIN BASIC PROTEIN-SPECIFIC T-CELLS, Journal of neuroscience research, 45(6), 1996, pp. 838-851
Citation: Re. Jones et Dn. Bourdette, HEMATOPOIETIC-DERIVED CD11B C+ RAT-CELLS POPULATE THE CENTRAL-NERVOUS-SYSTEM OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS-SUSCEPTIBLE SCID MOUSE LEWIS RAT BONE-MARROW CHIMERAS/, Neurology, 46(2), 1996, pp. 4041-4041
Authors:
WEINGBERG AD
SULLIVAN TJ
LERMON M
WALLIN JJ
BOURDETTE DN
FULTON RJ
OFFNER H
VANDERBARK AA
Citation: Ad. Weingberg et al., TARGET ORGAN EXPRESSION OF THE MRC OX-40 ANTIGEN ALLOWS FOR THE SELECTIVE DEPLETION OF MYELIN REACTIVE T-CELLS IN THE CENTRAL-NERVOUS-SYSTEM AND AMELIORATION OF AUTOIMMUNE ENCEPHALOMYELITIS, Journal of cellular biochemistry, 1995, pp. 157-157
Authors:
JONES RE
WHITHAM RH
SULLIVAN T
MASS M
BOURDETTE DN
Citation: Re. Jones et al., ENCEPHALITOGENIC T-LYMPHOCYTES DEVELOP FROM SJL J HEMATOPOIETIC-CELLSTRANSPLANTED INTO SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE/, Journal of neuroimmunology, 57(1-2), 1995, pp. 155-164
Authors:
BOURDETTE DN
WHITHAM RH
CHOU YK
OFFNER H
VANDENBARK AA
Citation: Dn. Bourdette et al., EPISODIC BURSTS OF ELEVATED MYELIN BASIC PROTEIN-SPECIFIC T-CELL FREQUENCIES OCCUR IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE-SCLEROSIS, Neurology, 45(4), 1995, pp. 465-466
Authors:
JONES RE
CHOU Y
YOUNG A
VANDENBARK A
BOURDETTE DN
Citation: Re. Jones et al., NAIVE LEWIS RAT SPLEEN-CELLS INDUCE PARALYSIS IN SCID MICE FOLLOWING INTRACISTERNAL (IC) TRANSFER, The FASEB journal, 8(5), 1994, pp. 10000754-10000754
Authors:
CHOU YK
BUENAFE AC
DEDRICK R
MORRISON WJ
BOURDETTE DN
WHITHAM R
ATHERTON J
LANE J
SPOOR E
HASHIM GA
OFFNER H
VANDENBARK AA
Citation: Yk. Chou et al., T-CELL RECEPTOR V-BETA GENE USAGE IN THE RECOGNITION OF MYELIN BASIC-PROTEIN BY CEREBROSPINAL FLUID-DERIVED AND BLOOD-DERIVED T-CELLS FROM PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of neuroscience research, 37(2), 1994, pp. 169-181
Authors:
JONES RE
CHOU Y
YOUNG A
VANDENBARK AA
BOURDETTE DN
Citation: Re. Jones et al., T-CELLS WITH ENCEPHALITOGENIC POTENTIAL FROM MULTIPLE-SCLEROSIS PATIENTS AND LEWIS RATS DO NOT INDUCE DISEASE IN SCID MICE FOLLOWING INTRACISTERNAL INJECTION, Neurology, 44(4), 1994, pp. 10000301-10000302
Citation: Dn. Bourdette, IMMUNITY TO TCR PEPTIDES IN MULTIPLE-SCLEROSIS .1. SUCCESSFUL IMMUNIZATION OF PATIENTS WITH SYNTHETIC V-AND-BETA,5.2 AND V-AND-BETA,6.1 CDR2 PEPTIDES (VOL 152, PG 2510, 1994), The Journal of immunology, 153(2), 1994, pp. 910-910
Authors:
WEINBERG AD
WALLIN JJ
JONES RE
SULLIVAN TJ
BOURDETTE DN
VANDENBARK AA
OFFNER H
Citation: Ad. Weinberg et al., TARGET ORGAN-SPECIFIC UP-REGULATION OF THE MRC OX-40 MARKER AND SELECTIVE PRODUCTION OF TH1 LYMPHOKINE MESSENGER-RNA BY ENCEPHALITOGENIC T-HELPER CELLS ISOLATED FROM THE SPINAL-CORD OF RATS WITH EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, The Journal of immunology, 152(9), 1994, pp. 4712-4721
Authors:
BOURDETTE DN
WHITHAM RH
CHOU YK
MORRISON WJ
ATHERTON J
KENNY C
LIEFELD D
HASHIM GA
OFFNER H
VANDENBARK AA
Citation: Dn. Bourdette et al., IMMUNITY TO TCR PEPTIDES IN MULTIPLE-SCLEROSIS .1. SUCCESSFUL IMMUNIZATION OF PATIENTS WITH SYNTHETIC V-BETA-5.2 AND V-BETA-6.1 CDR2 PEPTIDES, The Journal of immunology, 152(5), 1994, pp. 2510-2519
Authors:
CHOU YK
MORRISON WJ
WEINBERG AD
DEDRICK R
WHITHAM R
BOURDETTE DN
HASHIM G
OFFNER H
VANDENBARK AA
Citation: Yk. Chou et al., IMMUNITY TO TCR PEPTIDES IN MULTIPLE-SCLEROSIS .2. T-CELL RECOGNITIONOF V-BETA-5.2 AND V-BETA-6.1 CDR2 PEPTIDES, The Journal of immunology, 152(5), 1994, pp. 2520-2529
Authors:
VANDENBARK AA
BOURDETTE DN
WHITHAM R
CHOU YK
HASHIM GA
OFFNER H
Citation: Aa. Vandenbark et al., EPISODIC CHANGES IN T-CELL FREQUENCIES TO MYELIN BASIC-PROTEIN IN PATIENTS WITH MULTIPLE-SCLEROSIS, Neurology, 43(11), 1993, pp. 2416-2417